Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

B precursor type acute leukaemia

Not recruiting

Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

Registered drugNo placebo

Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Blinatumomab
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Substances studied in this area

The therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.

Pembrolizumab462 clinical trials Carboplatin340 clinical trials Cisplatin285 clinical trials Paclitaxel263 clinical trials Fluorouracil237 clinical trials Oxaliplatin227 clinical trials Nivolumab217 clinical trials Dexamethasone169 clinical trials Bevacizumab163 clinical trials

Neoplasms benign, malignant and unspecified (incl cysts and polyps) – page 229

Conditions in this area

Clinical trials in Neoplasms benign, malignant and unspecified (incl cysts and polyps)

3 898 clinical trials

Central nervous system lymphoma

Study on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma

HER2 positive breast cancer

Study on Trastuzumab Deruxtecan for Patients with Metastatic HER2-Positive Breast Cancer

Malignant peritoneal neoplasm+2

Study of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Oropharyngeal squamous cell carcinoma

Study on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma

Prostate cancer

Study on Imaging-Guided Surgery for Prostate Cancer Patients Using [68Ga]PSMA-HBED-CC and [99mTc]PSMA I&S

Hormone receptor positive HER2 negative breast cancer

Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Colorectal cancer metastatic

Study on Napabucasin with FOLFIRI for Adults with Metastatic Colorectal Cancer After Standard Treatments

Squamous cell carcinoma of head and neck

Study Comparing Weekly Low Dose Cisplatin to High Dose Every Three Weeks for Sarcopenic Patients with Head and Neck Cancer

B-cell lymphoma

Study of Rituximab, Polatuzumab Vedotin, and Glofitamab for Untreated Aggressive B-cell Lymphoma in Patients Over 60 Not Eligible for Full R-CHOP

Hodgkin's disease

Study of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin's Lymphoma Eligible for Stem Cell Transplant

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

B precursor type acute leukaemia

Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.